Understanding the immunology of the Zostavax shingles vaccine

Current Opinion in Immunology(2019)

引用 20|浏览52
暂无评分
摘要
•Zostavax is a safe vaccine to prevent shingles/postherpetic neuralgia.•Zostavax is a weak stimulator of innate immune responses.•Zostavax changes several metabolomic pathways which are correlated with immune outcome.•Zostavax elicits polyfunctional VZV-specific CD4+ T cells and low CD8+ T cell responses.•Zostavax boosts antibody responses which are strongly influenced by pre-existing antibody levels.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要